Digital pharmacy MYRX365 buys RealTime Clinic
MYRX365, a technology-based pharmacy company, has bought RealTime Clinic to gain access to its set of digital patient management tools.
Based in New York, MYRX365 uses consumer data and pharmacy technology to improve adherence and patient engagement for prescription drugs.
It aims to link patients, providers and pharmacies, putting patients in charge of their prescription management.
MYRX365 has an automated suite of software and fulfilment tools, and serves patients 365 days a year backed by delivery teams, and a single place of storage for patients’ health and medication histories.
RealTime Clinic offers both physician and patient-centred engagement tools designed to improve health outcomes.
Its technology platform enables patients to gather information by connecting existing devices, activity trackers, and other health related apps to their personal dashboards to track and assess progress, and access medical records and clinical notes.
Mohammad Ali, MYRX365’s CEO, said: “At MYRX365 we are singularly focused on improving access to medication and health information for all, while we manage costs and help our patients better their lives through actionable data.”
Nehal Swami, RealTime Clinic’s CEO, said: “We look forward to building upon the vision set forth by MYRX365 to bring patients, physicians and pharmacy together to improve adherence and health outcomes.”
No financial details were disclosed.
RealTime Clinic is part of the StartUp Health Academy, which began in 2011 as a 25-year programme to achieve a range of health “moonshots”.
These include access to care, cost to zero, ending cancer, ending addiction, brain health, and mental health and happiness.
The programme is backed by notable investors such as Chiesi Group, Esther Dyson, Brad Feld, Kaiser Permanente Ventures, Masimo, Novartis, Otsuka, Ping An Group, and SeventySix Capita.
StartUp Health has the world’s largest digital health portfolio with more than 280 companies spanning six continents and 23 countries.
News of this latest M&A activity follows figures from Mercom Capital Health earlier this month, that showed digital health acquisitions almost ground to a halt in Q1.
